Navigation Links
Kendle Named to 'Training Top 125'
Date:2/11/2010

CINCINNATI, Feb. 11 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced the Company has been named to Training magazine's "Training Top 125," an annual list of the 125 companies that are "unsurpassed in harnessing human capital."  Kendle was ranked # 114 and is one of only two companies from the CRO industry to be honored in 2010.

"Kendle's recognition among the Training Top 125 reflects our commitment and dedication to providing the most highly skilled and trained workforce in the CRO industry," said Daniel J. Hiltz, Ph.D., Director, Global Training and Development. "We recognize our associates are our most precious resource and invest in them accordingly so they in turn are able to deliver innovative and creative clinical development solutions for our customers."

The Training Top 125 rankings are based on a wide array of benchmarking statistics, including training budgets, number of training hours per employee program, goals, evaluation, measurement, amount of annual training per employee and more.  Training magazine also use a range of qualitative and quantitative factors to produce the rankings, including financial investment in employee development, scope of development programs and how closely these programs support business goals.

Training at Kendle is delivered via Kendle College, an international network of learning resources available to all associates. Kendle College is organized around a flexible curriculum with self-paced online courses and live collaborative experiences led by facilitators who are experts in specialized therapeutic and clinical research disciplines. The Company currently offers more than 700 classes to associates at all levels across the organization.

About Training Magazine

Training is a professional development magazine written for training, human resources and business management professionals in all industries that advocates training and workforce development as a business tool. Training also produces world-class conferences, expositions and digital products that focus on job-related, employer-sponsored training and education in the working world. Training is published by Nielsen Business Media, a part of The Nielsen Company, a global information and media company.  More information is available at www.trainingmag.com.  

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing drugs to market for the benefit of patients worldwide. As one of the world's largest global providers of Phase I-IV services, we offer experience spanning more than 100 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges.

Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 500, Cincinnati, OH 45202 or from the Company's Web site at www.kendle.com.

SOURCE Kendle International Inc.

RELATED LINKS
http://www.kendle.com

'/>"/>

SOURCE Kendle International Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Kendle Announces Third Quarter 2009 Results
2. Kendle Announces Details Regarding Second Quarter 2009 Earnings Conference Call and Webcast
3. Kendle to Share Insights at Drug Information Association 45th Annual Meeting
4. Kendle to Present at Upcoming Jefferies and Wachovia Securities Conferences
5. Kendle Announces First Quarter 2009 Earnings Conference Call and Webcast
6. Kendle Expands Asia/Pacific Operations with Opening of Additional Office in India
7. Kendle Revises Full Year 2008 Guidance
8. Kendle to Present at 27th Annual J.P. Morgan Healthcare Conference
9. Kendle Delivers Record Sales, Net Service Revenues and Earnings Per Share for Second Quarter 2008
10. Kendle Delivers Record Net Service Revenues and New Business Authorizations for First Quarter 2008
11. Kendle Promotes Simon S. Higginbotham to President; Appoints Alan J. Boyce as Chief Marketing Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( ... today the introduction of an innovative new design of the shoulder pad. The ... get maximum comfort while controlling your pain while using cold therapy. By utilizing ice ...
(Date:10/12/2017)... Rockville, Maryland (PRWEB) , ... October 12, 2017 ... ... a magnetic drug delivery system that we intend to develop to enable prevention ... regimens can lead to severe hearing loss, especially in pediatric patients. For cisplatin, ...
(Date:10/12/2017)... ... 12, 2017 , ... Leading pediatric oncology experts at Children’s National Health ... Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired ... Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... first interactive health literacy software tool, and the Cancer Patient Education Network (CPEN), ... patient education, today announce a new strategic alliance. , As CPEN’s strategic ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the University of California Berkeley, and other leading institutions in announcing the launch ... of institutions to change the way animals are raised for food. , Founding ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... for their devotion to personalized service, SMP Pharmacy Solutions announces ... the South Florida Business Journal,s 50 Fastest-Growing Companies, and listed ... national specialty pharmacy has found its niche.  To that end, ... honored by SFBJ as the 2017 Power Leader in Health ... his award in October, Bardisa said of the three achievements, ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, ... complete response letter from the U.S. Food and Drug ... approval of sirukumab for the treatment of moderately to ... indicates additional clinical data are needed to further evaluate ... to severely active RA. ...
(Date:9/19/2017)... Sept. 19, 2017   ZirMed Inc ., a recognized ... announced that it has been ranked #1 by its users ... Rankings 2017 User Survey. ZirMed was recognized as the ... hospitals and medical centers over 200 beds and holds one ... technology user survey history. ...
Breaking Medicine Technology: